Cargando…
免疫抑制治疗后三个月未获血液学反应的重型/极重型再生障碍性贫血患者六个月疗效评估
OBJECTIVE: To reassess the predictors for response at 6 months in patients with severe or very severe aplastic anemia(SAA/VSAA)who failed to respond to immunosuppressive therapy(IST)at 3 months. METHODS: We retrospectively analyzed the clinical data of 173 patients with SAA/VSAA from 2017 to 2018 wh...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250949/ https://www.ncbi.nlm.nih.gov/pubmed/35680597 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.05.008 |
Ejemplares similares
-
重型/极重型再生障碍性贫血患者红细胞寿命研究
Publicado: (2018) -
重型再生障碍性贫血免疫抑制治疗迟发血液学反应研究
Publicado: (2016) -
不同中性粒细胞计数阈值下极重型再生障碍性贫血免疫抑制治疗的血液学反应及生存研究
Publicado: (2016) -
治疗前铁过载对急性重型再生障碍性贫血免疫抑制治疗血液学反应的影响
Publicado: (2016) -
重型再生障碍性贫血的治疗进展
Publicado: (2015)